News

Featured News

23 July 2026

Moa Technology raises £22.2m Series C funding round

Parkwalk's latest investment in Moa Technology, a plant genetics company using proprietary technology to generate new herbicide candidates.
AgTech
Portfolio
23 June 2026

How investors are responding to inheritance tax changes

In a recent article in The i, Callum Mason examines how upcoming inheritance tax changes are already influencing investor behaviour.
Parkwalk

More news and updates

19 August 2026

Oxford Venture Fund – Coming soon

Funds
24 July 2026

Meet the Portfolio – Marley Health

AI Big Data & Software
Portfolio
23 July 2026

Moa Technology raises £22.2m Series C funding round

AgTech
Portfolio
15 July 2026

Meet the Portfolio – Paragraf

Hardware
Portfolio
9 July 2026

Pixel-Flo raises £5.25m Seed funding round

Hardware
Portfolio
8 July 2026

Meet the Portfolio – Brainomix

AI Big Data & Software
Portfolio
23 June 2026

How investors are responding to inheritance tax changes

Parkwalk
17 June 2026

Parkwalk backs Xen Quantum

Hardware
Portfolio
9 June 2026

Cambridge GaN Devices joins forces with NXP Semiconductors

Hardware
Portfolio
1 June 2026

Parkwalk sponsors new category at EISA Awards 2026

Parkwalk
15 May 2026

Parkwalk Portfolio Showcase 2026

Parkwalk
7 May 2026

Quantum Motion raises $160m Series C funding round

Quantum Computing
Portfolio

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.